United States

Pacific BioLabs acquires Bay Bioanalytical Laboratory

Monday, November 5, 2012 10:22 AM

Pacific BioLabs (PBL), a biological testing service based in Hercules, Calif., has acquired Bay Bioanalytical Laboratory (BBL), a contract laboratory also based in Hercules, adding analytical and bioanalytical chemistry to PBL's existing in vivo preclinical and microbiological testing services.

More... »

Mahoney becomes CEO and president of Boston Scientific

Friday, November 2, 2012 11:52 AM

Boston Scientific, a global developer, manufacturer and marketer of medical devices, has named Michael F. Mahoney its new CEO and president. Mahoney succeeds interim CEO William H. (Hank) Kucheman. Mahoney has also been appointed to the Boston Scientific board of directors. 

More... »

Lilly to expand Indianapolis insulin manufacturing operations

Friday, November 2, 2012 10:38 AM

Global pharmaceutical company Eli Lilly announced a $140 million expansion to the company's Indianapolis insulin manufacturing operations. The 80,000-square-foot expansion, which will enable the manufacturing of insulin cartridges to meet the growing diabetes demand in the U.S., represents one of the most significant investments in Lilly's U.S.-based manufacturing operations in the past decade.

More... »

ViaCyte appoints Altman to board of directors

Thursday, November 1, 2012 11:22 AM

ViaCyte, a San Diego-based regenerative medicine company developing transformative cell therapy for diabetes, as appointed Steve R. Altman to its board of directors.

More... »

Connecticut Innovations invests $1.5M in New Haven Pharmaceuticals

Wednesday, October 31, 2012 10:11 AM

More... »

Aveo refocuses on tivozanib, cuts 17% of workforce

Tuesday, October 30, 2012 01:43 PM

Aveo Oncology, a cancer therapeutics company based in Cambridge, Mass., has announced a strategic restructuring designed to optimize resources and reduce expenses to ensure Aveo is well positioned for a successful launch of tivozanib in renal cell carcinoma (RCC) and continued development in other cancer types, while maintaining a focused research engine.

More... »

Synthetic Biologics raises $10.8M financing

Tuesday, October 30, 2012 12:48 PM

Synthetic Biologics, an Ann Arbor, Mich.-based biotech that develops of synthetic biologics and innovative medicines for serious diseases and unmet medical needs, has entered into definitive stock purchase agreements with accredited investors to raise approximately $10.8 million in a private placement financing.

More... »

Principia Biopharma secures $12.5M second tranche in Series A financing

Tuesday, October 30, 2012 10:51 AM

Principia Biopharma, a South San Francisco-based privately held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology, has successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million.

More... »

LabConnect Reveals SciOps Support Team

Tuesday, October 30, 2012 09:53 AM

More... »

CRA Holdings acquires Radiant Research

Friday, October 26, 2012 03:16 PM

Kinderhook Industries has announced the acquisition of Radiant Research by CRA Holdings, one of its portfolio companies. The deal represents the eighth healthcare services transaction completed by Kinderhook. Financial terms of the transaction were not disclosed.

More... »